Related Articles
Organoids and epithelial ovarian cancer ‑ a future tool for personalized treatment decisions? (Review)
The prospect of discovering new biomarkers for ovarian cancer based on current knowledge of susceptibility loci and genetic variation (Review)
Pediatric haematopoiesis and related malignancies (Review) Corrigendum in /10.3892/ol.2021.12853
Annexin A2 inhibition suppresses ovarian cancer progression via regulating β-catenin/EMT
Methylation and ovarian cancer: Can DNA methylation be of diagnostic use? (Review)